Inflammation in acute ischemic stroke and its relevance to stroke critical care

Neurocritical Care

Volumn 9, Issue 1, 2008, Pages 125-138

  Emsley, Hedley C A ^a   Smith, Craig J ^b   Tyrrell, Pippa J ^b   Hopkins, Stephen J ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acute ischemic stroke; Critical care; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA CHEMOKINE; ALTEPLASE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; BETAMETHASONE; CLOPIDOGREL; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 6 ANTIBODY; MINOCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL INHIBITORY FACTOR; NITRIC OXIDE SYNTHASE; PLACEBO; PRAVASTATIN; PROSTAGLANDIN SYNTHASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UK 279276; UNCLASSIFIED DRUG; URIC ACID; VASCULAR CELL ADHESION MOLECULE 1;

ADRENERGIC SYSTEM; BLOOD BRAIN BARRIER; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL FUNCTION; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; ENCEPHALITIS; EXCITOTOXICITY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHERMIA; INTENSIVE CARE; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; UNSPECIFIED SIDE EFFECT; ACUTE DISEASE; PATHOPHYSIOLOGY; STROKE;

ACUTE DISEASE; BRAIN ISCHEMIA; CRITICAL CARE; ENCEPHALITIS; HUMANS; STROKE;

EID: 54449098491     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-9035-x     Document Type: Review

References (133)

1. SM Allan PJ Tyrrell NJ Rothwell 2005 Interleukin-1 and neuronal injury Nat Rev Immunol 5 8 629 40
2. HCA Emsley CJ Smith RF Georgiou A Vail SJ Hopkins NJ Rothwell PJ Tyrrell for the IL-1ra in Acute Stroke Investigators 2005 A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients J Neurol Neurosurg Psychiatry 76 10 1366 72
3. JC Baron 2001 Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications Cerebrovasc Dis 11 Suppl 1 2 8
4. E Shohami I Ginis JM Hallenbeck 1999 Dual role of tumor necrosis factor alpha in brain injury Cytokine Growth Factor Rev 10 119 30
5. Q Wang XN Tang MA Yenari 2007 The inflammatory response in stroke J Neuroimmunol 184 1-2 53 68
6. SJ Hopkins 2003 The pathophysiological role of cytokines Leg Med (Tokyo) 5 Suppl 1 S45 57
7. HCA Emsley PJ Tyrrell 2002 Inflammation and infection in clinical stroke J Cereb Blood Flow Metab 22 1399 419
8. BW McColl NJ Rothwell SM Allan 2007 Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms J Neurosci 27 16 4403 12
9. TJ DeGraba A-L Sirén L Penix RM McCarron R Hargraves S Sood KD Pettigrew JM Hallenbeck 1998 Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque Stroke 29 1405 10
10. G del Zoppo I Ginis JM Hallenbeck C Iadecola X Wang GZ Feuerstein 2000 Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia Brain Pathol 10 95 112
11. S Mun-Bryce GA Rosenberg 1998 Matrix metalloproteinases in cerebrovascular disease J Cereb Blood Flow Metab 18 11 1163 72 Review
12. GA Rosenberg 2002 Matrix metalloproteinases in neuroinflammation Glia 39 279 91
13. Zhang Z, Chopp M, Powers C. Temporal profile of microglial response following transient (2 h) middle cerebral artery occlusion. Brain Res 1997;744:189-98.
14. H Kato W Walz 2000 The initiation of the microglial response Brain Pathol 10 137 43
15. NJ Rothwell 1999 Cytokines-killers in the brain? J Physiol 514 3 17
16. R Gregersen K Lambertsen B Finsen 2000 Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice J Cereb Blood Flow Metab 20 53 65
17. 3H]PK11195 binding to activated microglia J Neurocytol 26 77 82
18. 11C]PK11195 and positron emission tomography in patients after ischemic stroke Neuroreport 11 2957 60
19. 11C](R)-PK11195 PET study Neuroimage 24 2 591 5
20. A Saleh M Schroeter C Jonkmanns HP Hartung U Modder S Jander 2004 In vivo MRI of brain inflammation in human ischaemic stroke Brain 127 7 1670 7
21. A Saleh M Schroeter A Ringelstein HP Hartung M Siebler U Modder S Jander 2007 Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke Stroke 38 10 2733 7
22. C Pozzilli GL Lenzi C Argentino L Bozzao M Rasura F Giubilei C Fieschi 1985 Peripheral white blood cell count in cerebral ischemic infarction Acta Neurol Scand 71 396 400
23. E D'Erasmo M Acca FS Celi G Mazzuoli 1991 Correlation between plasma fibrinogen levels and white blood cell count after cerebral infarction Stroke 22 1089
24. C Pozzilli GL Lenzi C Argentino A Carolei M Rasura A Signore L Bozzao P Pozzilli 1985 Imaging of leukocytic infiltration in human cerebral infarcts Stroke 16 251 5
25. P-Y Wang C-H Kao M-Y Mui S-J Wang 1993 Leukocyte infiltration in acute hemispheric stroke Stroke 24 236 40
26. SE Akopov NA Simonian GS Grigorian 1996 Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage Stroke 27 1739 43
27. CJ Price DK Menon AM Peters JR Ballinger RW Barber KK Balan A Lynch JH Xuereb T Fryer JV Guadagno EA Warburton 2004 Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study Stroke 35 7 1659 64
28. Adams RD, Sidman RL. Introduction to neuropathology. New York: McGraw-Hill Inc.; 1968. p. 172-5.
29. R Sörnäs H Östlund R Müller 1972 Cerebrospinal fluid cytology after stroke Arch Neurol 26 489 501
30. WC Jean SR Spellman ES Nussbaum WC Low 1998 Reperfusion injury after focal cerebral ischemia: role of inflammation and the therapeutic horizon Neurosurgery 43 1382 97
31. R Berti AJ Williams JR Moffett SL Hale LC Velarde PJ Elliott C Yao JR Dave FC Tortella 2002 Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury J Cereb Blood Flow Metab 22 9 1068 79
32. Y Okada BR Copeland E Mori MM Tung WS Thomas GJ del Zoppo 1994 P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion Stroke 25 1 202 11
33. HP Haring EL Berg N Tsurushita M Tagaya GJ del Zoppo 1996 E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia Stroke 27 8 1386 91
34. GJ del Zoppo GW Schmid-Schonbein E Mori BR Copeland CM Chang 1991 Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons Stroke 22 10 1276 83
35. SJ Hopkins 2007 Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration Acta Biomed 78 Suppl 1 231 47
36. J Kwan P Hand 2007 Infection after acute stroke is associated with poor short-term outcome Acta Neurol Scand 115 5 331 8
37. A Chamorro X Urra AM Planas 2007 Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression Stroke 38 3 1097 103
38. C Woiciechowsky B Schoning WR Lanksch HD Volk WD Docke 1999 Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression J Mol Med 77 11 769 80
39. JS Meyer E Stoica I Pascu K Shimazu A Hartmann 1973 Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage Brain 96 2 277 88
40. MG Myers JW Norris VC Hachniski MJ Sole 1981 Plasma norepinephrine in stroke Stroke 12 2 200 4
41. D Sander K Winbeck J Klingelhofer T Etgen B Conrad 2001 Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke Neurology 57 5 833 8
42. S Meyer M Strittmatter C Fischer T Georg B Schmitz 2004 Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex Neuroreport 15 2 357 61
43. H Ay WJ Koroshetz T Benner MG Vangel C Melinosky EM Arsava C Ayata M Zhu LH Schwamm AG Sorensen 2006 Neuroanatomic correlates of stroke-related myocardial injury Neurology 66 9 1325 9
44. A Chamorro S Amaro M Vargas V Obach A Cervera M Gomez-Choco F Torres AM Planas 2007 Catecholamines, infection, and death in acute ischemic stroke J Neurol Sci 252 1 29 35
45. T Olsson 1990 Urinary free cortisol excretion shortly after ischaemic stroke J Intern Med 228 2 177 81
46. K Fassbender R Schmidt R Mößner M Daffertshofer M Hennerici 1994 Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke: relation to acute confusional state, extent of brain damage, and clinical outcome Stroke 25 1105 8
47. HCA Emsley CJ Smith CM Gavin RF Georgiou A Vail EM Barberan JM Hallenbeck GJ del Zoppo NJ Rothwell PJ Tyrrell SJ Hopkins 2003 An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis J Neuroimmunol 139 93 101
48. PA O'Neill I Davies KJ Fullerton D Bennett 1991 Stress hormone and blood glucose response following acute stroke in the elderly Stroke 22 7 842 7
49. K Murros R Fogelholm S Kettunen AL Vuorela J Valve 1992 Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction J Neurol Sci 111 1 59 64
50. A Slowik W Turaj J Pankiewicz T Dziedzic P Szermer A Szczudlik 2002 Hypercortisolemia in acute stroke is related to the inflammatory response J Neurol Sci 196 1-2 27 32
51. CJ Smith HCA Emsley CM Gavin RF Georgiou A Vail EM Barberan GJ del Zoppo JM Hallenbeck NJ Rothwell SJ Hopkins PJ Tyrrell 2004 Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome BMC Neurol 4 2
52. A Makikallio K Juha M Timo T Mikko V Olli S Kyosti H Heikki M Vilho 2007 Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality Curr Neurovasc Res 4 3 170 5
53. T Olsson N Marklund Y Gustafson B Näsman 1992 Abnormalities at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke Stroke 23 1573 6
54. Å Johansson T Olsson B Carlberg K Karlsson M Fagerlund 1997 Hypercortisolism after stroke-partly cytokine-mediated? J Neurol Sci 147 43 7
55. A Szczudlik T Dziedzic S Bartus A Slowik A Kieltyka 2004 Serum interleukin-6 predicts cortisol release in acute stroke patients J Endocrinol Invest 27 1 37 41
56. G Ramadori B Christ 1999 Cytokines and the hepatic acute-phase response Semin Liver Dis 19 141 55
57. J Syrjänen A-M Teppo VV Valtonen M Iivanainen CPJ Maury 1989 Acute phase response in cerebral infarction J Clin Pathol 42 63 8
58. KW Muir CJ Weir W Alwan IB Squire KR Lees 1999 C-reactive protein and outcome after ischemic stroke Stroke 30 981 5
59. M Di Napoli F Papa V Bocola 2001 Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke Stroke 32 133 8
60. A Silvestri C Vitale F Ferretti D Onorati M Fini GM Rosano 2004 Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke J Am Geriatr Soc 52 9 1586 7
61. T Hoshi K Kitagawa H Yamagami S Furukado H Hougaku M Hori 2005 Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction Stroke 36 4 768 72
62. M Di Napoli 2001 Early inflammatory response in ischemic stroke Thromb Res 103 261 4
63. K Winbeck H Poppert T Etgen B Conrad D Sander 2002 Prognostic relevance of early serial C-reactive protein measurements after first ischaemic stroke Stroke 33 2459 64
64. L Wilhelmsen K Svärdsudd K Korsan-Bengtsen B Larsson L Welin G Tibblin 1984 Fibrinogen as a risk factor for stroke and myocardial infarction N Engl J Med 311 501 5
65. SC Kofoed HH Wittrup H Sillesen BG Nordestgaard 2003 Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study Eur Heart J 24 567 76
66. PM Rothwell SC Howard DA Power SA Gutnikov A Algra J van Gijn TG Clark MF Murphy CP Warlow 2004 Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke Stroke 35 2300 5
67. J Belch M Mclaren J Hanslip A Hill D Davidson 1998 The white blood cell and plasma fibrinogen in thrombotic stroke: a significant correlation Int Angiol 17 120 4
68. A Chamorro N Vila C Ascaso A Saiz J Montalvo P Alonso E Tolosa 1995 Early prediction of stroke severity: role of the erythrocyte sedimentation rate Stroke 26 573 6
69. M Balestrino D Partinico C Finocchi C Gandolfo 1998 White blood cell count and erythrocyte sedimentation rate correlate with outcome in patients with acute ischemic stroke J Stroke Cerebrovasc Dis 7 139 44
70. T Anuk EB Assayag R Rotstein R Fusman D Zeltser S Berliner D Avitzour I Shapira N Arber NM Bornstein 2002 Prognostic implications of admission inflammatory profile in acute ischemic neurological events Acta Neurol Scand 106 196 9
71. RS Bhatia RK Garg SP Gaur AM Kar R Shukla A Agarwal R Verma 2004 Predictive value of routine hematological and biochemical parameters on 30-day fatality in acute stroke Neurol India 52 220 3
72. A Chamorro N Vila R Blanc A Saiz C Ascaso R Deulofeu 1997 The prognostic value of the acute-phase response in stroke recurrence Eur J Neurol 4 491 7
73. W Hacke S Schwab M Horn M Spranger M De Georgia R von Kummer 1996 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs Arch Neurol 53 4 309 15
74. J Serena M Blanco M Castellanos Y Silva J Vivancos MA Moro R Leira I Lizasoain J Castillo A Davalos 2005 The prediction of malignant cerebral infarction by molecular brain barrier disruption markers Stroke 36 9 1921 6
75. K Vahedi J Hofmeijer E Juettler E Vicaut B George A Algra GJ Amelink P Schmiedeck S Schwab PM Rothwell MG Bousser HB van der Worp W Hacke DECIMAL, DESTINY, and HAMLET investigators 2007 Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials Lancet Neurol 6 215 22
76. SE Kasner AM Demchuk J Berrouschot E Schmutzhard L Harms P Verro JA Chalela R Abbur H McGrade I Christou DW Krieger 2001 Predictors of fatal brain edema in massive hemispheric ischemic stroke Stroke 32 9 2117 23
77. J Bamford P Sandercock M Dennis C Warlow 1991 Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 337 1521 6
78. H Tei S Uchiyama K Ohara M Kobayashi Y Uchiyama M Fukuzawa 2000 Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project Stroke 31 9 2049 54
79. M Castellanos J Castillo MM García R Leira J Serena A Chamorro A Dávalos 2002 Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target Stroke 33 982 7
80. HJ Audebert TS Pellkofer ML Wimmer RL Haberl 2004 Progression in lacunar stroke is related to elevated acute phase parameters Eur Neurol 51 3 125 31
81. JM Wardlaw PA Sandercock MS Dennis J Starr 2003 Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34 3 806 12
82. P Bath 2004 High blood pressure as risk factor and prognostic predictor in acute ischaemic stroke: when and how to treat it? Cerebrovasc Dis 17 Suppl 1 51 7
83. CU Chae RT Lee N Rifai PM Ridker 2001 Blood pressure and inflammation in apparently healthy men Hypertension 38 399 403
84. M Di Napoli F Papa 2003 Association between blood pressure and C-reactive protein levels in acute ischemic stroke Hypertension 42 6 1117 23
85. R Garg A Chaudhuri F Munschauer P Dandona 2006 Hyperglycaemia, insulin, and acute ischaemic stroke: a mechanistic justification for a trial of insulin infusion therapy Stroke 37 267 73
86. CS Gray AJ Hildreth PA Sandercock JE O'Connell DE Johnston NE Cartlidge JM Bamford OF James KG Alberti GIST Trialists Collaboration 2007 Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) Lancet Neurol 6 5 397 406
87. F Li T Omae M Fisher 1999 Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats Stroke 30 2464 70
88. H Chen M Chopp KM Welch 1991 Effect of mild hyperthermia on the ischemic infarct volume after middle cerebral artery occlusion in the rat Neurology 41 1133 5
89. E Morikawa MD Ginsberg WD Dietrich RC Duncan S Kraydieh MY Globus R Busto 1992 The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat J Cereb Blood Flow Metab 12 3 380 9
90. Y Kim R Busto WD Dietrich S Kraydieh MD Ginsberg 1996 Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia Stroke 27 12 2274 80
91. J Reith HS Jørgensen PM Pedersen H Nakayama HO Raaschou LL Jeppesen TS Olsen 1996 Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome Lancet 347 422 5
92. G Boysen H Christensen 2001 Stroke severity determines body temperature in acute stroke Stroke 32 413 7
93. J Castillo A Dávalos J Marrugat M Noya 1998 Timing for fever-related brain damage in acute ischemic stroke Stroke 29 12 2455 60
94. R Leira M Rodríguez-Yáñez M Castellanos M Blanco F Nombela T Sobrino I Lizasoain A Dávalos J Castillo 2006 Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke J Intern Med 260 4 343 9
95. C Hajat S Hajat P Sharma 2000 Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients Stroke 31 2 410 4
96. LP Kammersgaard HS Jørgensen JA Rungby J Reith H Nakayama UJ Weber J Houth TS Olsen 2002 Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study Stroke 33 7 1759 62
97. I Marshall B Karaszewski JM Wardlaw V Cvoro K Wartolowska PA Armitage T Carpenter ME Bastin A Farrall K Haga 2006 Measurement of regional brain temperature using proton spectroscopic imaging: validation and application to acute ischemic stroke Magn Reson Imaging 24 6 699 706
98. HJ Audebert MM Rott T Eck RL Haberl 2004 Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis Stroke 35 9 2128 33
99. J Kaur Z Zhao GM Klein EH Lo AM Buchan 2004 The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24 9 945 63
100. M Castellanos R Leira J Serena JM Pumar I Lizasoain J Castillo A Dávalos 2003 Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke Stroke 34 40 6
101. J Montaner CA Molina J Monasterio S Abilleira JF Arenillas M Ribó M Quintana J Alvarez-Sabín 2003 Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 107 4 598 603
102. JH Heo SH Kim KY Lee EH Kim CK Chu JM Nam 2003 Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure Stroke 34 6 e48 50
103. S Amaro D Soy V Obach A Cervera AM Planas A Chamorro 2007 A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke Stroke 38 7 2173 5
104. TA Kent VM Soukup RH Fabian 2001 Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse Stroke 32 10 2318 27
105. Antithrombotic Trialists' Collaboration 2002 Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, stroke in high risk patients BMJ 324 71 86
106. PM Ridker M Cushman MJ Stampfer RP Tracy CH Hennekens 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 973 9
107. SR Steinhubl JJ Badimon DL Bhatt JM Herbert TF Luscher 2007 Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease Vasc Med 12 113 22
108. P Amarenco P Lavallee PJ Touboul 2004 Stroke prevention, blood cholesterol, and statins Lancet Neurol 3 271 8
109. MA Albert E Danielson N Rifai PM Ridker for the PRINCE investigators 2001 Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomised trial, cohort study JAMA 286 64 70
110. M Di Napoli F Papa 2001 Inflammation, statins, and outcome after ischemic stroke Stroke 32 2446 7
111. M Cimino P Gelosa A Gianella E Nobili E Tremoli L Sironi 2007 Statins: multiple mechanisms of action in the ischemic brain Neuroscientist 13 3 208 13
112. J Alvarez-Sabin R Huertas M Quintana M Rubiera P Delgado M Ribo CA Molina J Montaner 2007 Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator Stroke 38 3 1076 8
113. The Heart Outcomes Prevention Evaluation Study Investigators 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 145 53
114. PROGRESS Collaborative Group 2001 Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Lancet 358 1033 41
115. B Dahlöf RB Devereux SE Kjeldsen S Julius G Beevers U de Faire F Fyhrquist H Ibsen K Kristiansson O Lederballe-Pedersen LH Lindholm MS Nieminen P Omvik S Oparil H Wedel LIFE study group 2002 Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 995 1003
116. P Libby 2001 Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 3 365 72
117. Y Suzuki M Ruiz-Ortega O Lorenzo M Ruperez V Esteban J Egido 2003 Inflammation and angiotensin II Int J Biochem Cell Biol 35 881 900
118. Enlimomab Acute Stroke Trial Investigators 2001 Use of anti-ICAM-1 therapy in ischemic stroke: results of the enlimomab acute stroke trial Neurology 57 1428 34
119. K Furuya H Takeda S Azhar RM McCarron Y Chen CA Ruetzler KM Wolcott TJ DeGraba R Rothlein TE Hugli GJ del Zoppo JM Hallenbeck 2001 Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study Stroke 32 2665 74
120. M Krams KR Lees W Hacke AP Grieve J-M Orgogozo GA Ford for the ASTIN Study Investigators 2003 Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke Stroke 34 2543 8
121. R Härtl L Schürer GW Schmid-Schönbein GJ del Zoppo 1996 Experimental antileukocyte interventions in cerebral ischemia J Cereb Blood Flow Metab 16 1108 19
122. DW Krieger MA Yenari 2004 Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke 35 6 1482 9
123. GJ Wang HY Deng CM Maier GH Sun MA Yenari 2002 Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke Neuroscience 114 4 1081 90
124. HS Han M Karabiyikoglu S Kelly RA Sobel MA Yenari 2003 Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke J Cereb Blood Flow Metab 23 5 589 98
125. Hypothermia after Cardiac Arrest Study Group 2002 Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med 346 8 549 56
126. TM Hemmen PD Lyden 2007 Induced hypothermia for acute stroke Stroke 38 Suppl 2 794 9
127. H Adams R Adams G Del Zoppo LB Goldstein Stroke Council of the American Heart Association; American Stroke Association 2005 Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association Stroke 36 4 916 23
128. Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2002;(2):CD000064.
129. SM Davis GA Donnan 2004 Steroids for stroke: another potential therapy discarded prematurely? Stroke 35 230 1
130. VW Yong J Wells F Giuliani S Casha C Power LM Metz 2004 The promise of minocycline in neurology Lancet Neurol 3 12 744 51
131. Y Lampl M Boaz R Gilad M Lorberboym R Dabby A Rapoport M Anca-Hershkowitz M Sadeh 2007 Minocycline treatment in acute stroke: an open-label, evaluator-blinded study Neurology 69 14 1404 10
132. N Nishimoto T Kishimoto 2006 Interleukin 6: from bench to bedside Nat Clin Pract Rheumatol 2 11 619 26
133. Clark SR, McMahon CJ, Gueorguieva I, Rowland M, Scarth S, Georgiou R, Tyrrell PJ, Hopkins SJ, Rothwell NJ. Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations. J Cereb Blood Flow Metab. 2007 Aug 8; [Epub ahead of print].